Table 1. Baseline characteristics in patients with CHD and control group.
| Characteristics | CHD (n = 300) | Control (n = 100) | p value |
|---|---|---|---|
| Age, median (range), y | 59 (40–86) | 61 (31–87) | 0.531 |
| Men, No. (%) | 205 (68.3) | 72 (72.0) | 0.491 |
| Medical history, No. (%) | |||
| Hypertension | 155 (51.6) | 56 (56.0) | 0.450 |
| Diabetes | 75 (25.0) | 19 (19.0) | 0.221 |
| Current smoker | 140 (46.7) | 41 (41.0) | 0.325 |
| Previous medication, No. (%) | |||
| β-blocker | 26 (8.7) | 11 (11.0) | 0.484 |
| ACEI/ARB | 126 (42.0) | 44 (44.0) | 0.729 |
| Statin | 100 (33.3) | 40 (40.07) | 0.225 |
| Biochemistry detection | |||
| WBC count, × 109/L, median (range) | 6.52 (3.46–17.62) | 6.22 (2.98–13.96) | 0.212 |
| HDL-C, mmol/L, median (range) | 1.03 (0.57–1.88) | 0.95 (0.47–3.73) | 0.039 |
| LDL-C, mmol/L, median (range) | 1.93 (0.84–4.32) | 2.41 (0.81–7.30) | <0.001 |
| TG, mmol/L, median (range) | 1.11 (0.42–2.78) | 1.83 (0.38–6.27) | <0.001 |
| TC, mmol/L, median (range) | 3.26 (1.95–6.03) | 3.84 (1.93–8.93) | <0.001 |
| CR, μmol/L, median (range) | 94 (53–319) | 96 (59–241) | 0.934 |
| UA, μmol/L, median (range) | 259 (108–476) | 267 (117–500) | 0.952 |
Note:
TG, Triglyceride; TC, Total cholesterol; CR, Creatinine; UA, Uric Acid; BMI, body mass index; HDL-C, High-density lipoprotein cholesterol; LDL-C, Low-density lipoprotein cholesterol; miRNA, micro-RNA.